 CAMBRIDGE, Mass., March 21, 2022 GLOBE NEWSWIRE -- Vigil Neuroscience, Inc. Nasdaq: VIGL, a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that Ivana Magovčević-Liebisch, Ph.D., J.D., President Chief Executive Officer, will participate in a fireside chat at the Stifel 2022 CNS Days virtual conference on Monday, March 28, 2022 at 9:45 a.m. ET. 